Michael Schaefer Selected Research

Placebos

4/2021	Effects of Open-Label Placebos on State Anxiety and Glucocorticoid Stress Responses.
1/2021	Comment on Evers et al. "What Should Clinicians Tell Patients about Placebo and Nocebo Effects?": Open-Label Placebos May Reduce Feelings of Hunger during Weight Loss.
10/2019	Effects of a probiotic treatment (Enterococcus faecalis) and open-label placebo on symptoms of allergic rhinitis: study protocol for a randomised controlled trial.
1/2018	Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis.
1/2016	Open-Label Placebos Improve Symptoms in Allergic Rhinitis: A Randomized Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Schaefer Research Topics

Disease

11	Pain (Aches) 04/2021 - 01/2003
9	Neoplasms (Cancer) 01/2022 - 01/2014
8	Inflammation (Inflammations) 01/2021 - 12/2006
6	Ischemia 10/2019 - 08/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 03/2014
4	Hyperalgesia 01/2017 - 02/2009
3	Edema (Dropsy) 03/2021 - 01/2006
3	Allergic Rhinitis 10/2019 - 01/2016
3	Hypoxia (Hypoxemia) 01/2016 - 02/2012
2	Fibrosis (Cirrhosis) 06/2022 - 03/2021
2	Hyperthermia 01/2022 - 01/2021
2	Wounds and Injuries (Trauma) 09/2021 - 05/2011
2	Body Weight (Weight, Body) 03/2021 - 01/2004
2	Mucolipidoses (Sialidosis) 01/2021 - 08/2014
2	Neuralgia (Stump Neuralgia) 11/2019 - 12/2013
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2017 - 02/2012
2	Atherosclerosis 01/2017 - 06/2006
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2016 - 01/2016
2	Brain Edema (Cerebral Edema) 12/2016 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 11/2014 - 01/2014
2	Vomiting 04/2014 - 02/2013
2	Nausea 04/2014 - 02/2013
2	Melanoma (Melanoma, Malignant) 01/2014 - 06/2012
2	Alzheimer Disease (Alzheimer's Disease) 05/2009 - 03/2007
1	Ureteral Obstruction 06/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2022
1	Hypertension (High Blood Pressure) 06/2022
1	Leukemia 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Adenocarcinoma 09/2021
1	Animal Disease Models 03/2021
1	Proteinuria 03/2021
1	Channelopathies 03/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Lipoma (Lipomata) 12/2020
1	Simpson-Golabi-Behmel syndrome 12/2020
1	Pheochromocytoma 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Chronic Cough 11/2019
1	Chronic Pain 11/2019
1	Heart Failure 01/2019
1	Contracture 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2017
1	Skin Neoplasms (Skin Cancer) 08/2017
1	Atherosclerotic Plaque (Atheroma) 01/2017

Drug/Important Bio-Agent (IBA)

7	TRPC6 Cation ChannelIBA 06/2022 - 02/2012
6	Adenosine Triphosphate (ATP)IBA 01/2020 - 08/2002
5	PlacebosIBA 04/2021 - 01/2016
5	CationsIBA 01/2021 - 11/2007
3	SH045IBA 06/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2012
3	CalciumIBA 02/2019 - 01/2012
3	Analgesics (Analgesic Drugs)IBA 08/2017 - 04/2009
3	CytokinesIBA 01/2014 - 01/2006
3	Amyloid (Amyloid Fibrils)IBA 07/2012 - 03/2007
3	Opioid Analgesics (Opioids)IBA 04/2009 - 01/2003
2	Ion Channels (Ion Channel)IBA 01/2021 - 01/2016
2	sulforaphaneIBA 01/2021 - 03/2014
2	LigandsIBA 09/2017 - 12/2006
2	Purinergic P2X7 ReceptorsIBA 12/2016 - 01/2016
2	Purinergic Receptors (Receptors, Purine)IBA 01/2016 - 01/2016
2	Narcotics (Narcotic Analgesics)IBA 02/2013 - 10/2009
2	Opioid Receptors (Opioid Receptor)IBA 04/2009 - 12/2006
2	Opioid Peptides (Opioid Peptide)IBA 04/2009 - 12/2006
1	Fibronectins (Fibronectin)IBA 06/2022
1	valdecoxib (Bextra)FDA Link 01/2022
1	SilverIBA 09/2021
1	Thioctic Acid (Lipoic Acid)IBA 09/2021
1	Transient Receptor Potential ChannelsIBA 03/2021
1	Two-Pore ChannelsIBA 01/2021
1	isothiocyanic acidIBA 01/2021
1	tetrandrineIBA 01/2021
1	TensinsIBA 12/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2020
1	artemisinin (artemisinine)IBA 01/2020
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 01/2020
1	Purinergic P2X3 ReceptorsIBA 11/2019
1	MelatoninIBA 10/2019
1	Bretschneider cardioplegic solutionIBA 02/2019
1	Cardioplegic SolutionsIBA 02/2019
1	HTK-N solutionIBA 02/2019
1	Tyrode's solutionIBA 02/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	larixolIBA 11/2017
1	Pharmaceutical PreparationsIBA 08/2017
1	Celecoxib (Celebrex)FDA Link 08/2017
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2017
1	1-penicillamyl-Leu(2)- oxytocinIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2003
4	Induced Heart Arrest (Cardioplegia) 10/2019 - 08/2002
2	Analgesia 01/2015 - 12/2006
1	Stents 09/2021
1	Catheters 09/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Organ Transplantation 01/2018